Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SAVAGE, Kerry J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 25

  • Page / 1
Export

Selection :

  • and

Peripheral T-cell lymphomasSAVAGE, Kerry J.Blood reviews. 2007, Vol 21, Num 4, pp 201-216, issn 0268-960X, 16 p.Article

Molecular signatures of lymphomaSAVAGE, Kerry J; GASCOYNE, Randy D.International journal of hematology. 2004, Vol 80, Num 5, pp 401-409, issn 0925-5710, 9 p.Article

Modern management of lymphocyte predominant Hodgkin lymphomaXING, Katharine H; SAVAGE, Kerry J.British journal of haematology. 2013, Vol 161, Num 3, pp 316-329, issn 0007-1048, 14 p.Article

Anaplastic large cell lymphoma, ALK-negativeFERRERI, Andres J. M; GOVI, Silvia; PILERI, Stefano A et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 206-215, issn 1040-8428, 10 p.Article

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneJOHNSON, Nathalie A; SLACK, Graham W; CHAN, Wing C et al.Journal of clinical oncology. 2012, Vol 30, Num 28, pp 3452-3459, issn 0732-183X, 8 p.Article

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalJOHNSON, Nathalie A; SAVAGE, Kerry J; CONNORS, Joseph M et al.Blood. 2009, Vol 114, Num 11, pp 2273-2279, issn 0006-4971, 7 p.Article

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapySAVAGE, Kerry J; JOHNSON, Nathalie A; BEN-NERIAH, Susana et al.Blood. 2009, Vol 114, Num 17, pp 3533-3537, issn 0006-4971, 5 p.Article

ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified : report from the International Peripheral T-Cell Lymphoma ProjectSAVAGE, Kerry J; LEE HARRIS, Nancy; ARMITAGE, James O et al.Blood. 2008, Vol 111, Num 12, pp 5496-5504, issn 0006-4971, 9 p.Article

Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II StudyPETRELLA, Teresa M; TOZER, Richard; HAGERMAN, Linda et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3396-3401, issn 0732-183X, 6 p.Article

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's LymphomaYOUNES, Anas; GOPAL, Ajay K; FORERO-TORRES, Andres et al.Journal of clinical oncology. 2012, Vol 30, Num 18, pp 2183-2189, issn 0732-183X, 7 p.Article

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma ProjectWEISENBURGER, Dennis D; SAVAGE, Kerry J; CAMPO, Elias et al.Blood. 2011, Vol 117, Num 12, pp 3402-3408, issn 0006-4971, 7 p.Article

Fatal postlymphoma chemotherapy hepatitis b reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patientLAW, Joanna K; AL ALI, Jaber; HARRIGAN, P. Richard et al.American journal of hematology. 2006, Vol 81, Num 12, pp 969-972, issn 0361-8609, 4 p.Article

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term SurvivorsMAK, Vivien; HAMM, Jeremey; CHHANABHAI, Mukesh et al.Journal of clinical oncology. 2013, Vol 31, Num 16, pp 1970-1976, issn 0732-183X, 7 p.Article

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersSTEIDL, Christian; SHAH, Sohrab P; MCPHERSON, Andrew et al.Nature (London). 2011, Vol 471, Num 7338, pp 377-381, issn 0028-0836, 5 p.Article

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL StudyO'CONNOR, Owen A; PRO, Barbara; JACOBSEN, Eric et al.Journal of clinical oncology. 2011, Vol 29, Num 9, pp 1182-1189, issn 0732-183X, 8 p.Article

Long-Term Outcomes for Patients With Limited Stage Follicular Lymphoma: Involved Regional Radiotherapy Versus Involved Node RadiotherapyCAMPBELL, Belinda A; VOSS, Nick; WOODS, Ryan et al.Cancer. 2010, Vol 116, Num 16, pp 3797-3806, issn 0008-543X, 10 p.Article

NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtvnesFEUERHAKE, Friedrich; KUTOK, Jeffery L; SAVAGE, Kerry J et al.Blood. 2005, Vol 106, Num 4, pp 1392-1399, issn 0006-4971, 8 p.Article

Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma ProjectFEDERICO, Massimo; RUDIGER, Thomas; WEISENBURGER, Dennis D et al.Journal of clinical oncology. 2013, Vol 31, Num 2, pp 240-246, issn 0732-183X, 7 p.Article

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma ProjectMITROVIC, Zdravko; PERRY, Anamarija M; SAVAGE, Kerry J et al.American journal of hematology. 2012, Vol 87, Num 8, pp 790-794, issn 0361-8609, 5 p.Article

Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphomaNELSON, Marilu; HORSMAN, Douglas E; WEISENBURGER, Dennis D et al.British journal of haematology. 2008, Vol 141, Num 4, pp 461-469, issn 0007-1048, 9 p.Article

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's LymphomaAL-TOURAH, Abdulwahab J; GILL, Karamjit K; CHHANABHAI, Mukesh et al.Journal of clinical oncology. 2008, Vol 26, Num 32, pp 5165-5169, issn 0732-183X, 5 p.Article

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaROBERTSON, Michael J; KAHL, Brad S; DARSTEIN, Christelle et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1741-1746, issn 0732-183X, 6 p.Article

Molecular profiling of diffuse large B-cell lymphorna identifies robust subtypes including one characterized by host inflammatory responseMONTI, Stefano; SAVAGE, Kerry J; DAL CIN, Paola et al.Blood. 2005, Vol 105, Num 5, pp 1851-1861, issn 0006-4971, 11 p.Article

The phosphodiesterase PDE4B limits cAMP-associated PI3k/AKT-dependent apoptosis in diffuse large B-cell lymphomaSMITH, Peter G; FENGFEI WANG; WILKINSON, Kathryn N et al.Blood. 2005, Vol 105, Num 1, pp 308-316, issn 0006-4971, 9 p.Article

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaSAVAGE, Kerry J; MONTI, Stefano; AGUIAR, Ricardo C. T et al.Blood. 2003, Vol 102, Num 12, pp 3871-3879, issn 0006-4971, 9 p.Article

  • Page / 1